Clinical Trial Update: Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]

View source ↗

Summary

Phase 2 trial testing Rituximab plus Beta-Glucan in chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Beta Glucan (beta-glucan)
• Rituxan (rituximab)

Snippet

Sponsor: University of Louisville | Conditions: Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic | Phase 2 | Status: TERMINATED | Results posted: 2013-06-24